Erinacine A Erinacin A
Erinacine A Erinacin A Basic information
- Product Name:
- Erinacine A Erinacin A
- Synonyms:
-
- Erinacine A Erinacin A
- Cyclohept[e]indene-8-carboxaldehyde, 2,3,3a,4,5,5a,6,7-octahydro-3a,5a-dimethyl-1-(1-methylethyl)-6-(β-D-xylopyranosyloxy)-, (3aR,5aR,6S)-
- (+)-Erinacin A
- CAS:
- 156101-08-5
- MF:
- C25H36O6
- MW:
- 432.55
- Mol File:
- 156101-08-5.mol
Erinacine A Erinacin A Chemical Properties
- Boiling point:
- 610.8±55.0 °C(Predicted)
- Density
- 1.24±0.1 g/cm3(Predicted)
- solubility
- Acetonitrile: Soluble
Methanol: Soluble - form
- Solid
- pka
- 13.01±0.70(Predicted)
- color
- Light yellow to yellow
Erinacine A Erinacin A Usage And Synthesis
Uses
(+)-Erinacin A is a diterpenoid derivative isolated from the mushroom Hericium erinaceum. It can increase the catecholamine and nerve growth factor (NGF) content in the central nervous system of rats.
in vivo
(+)-Erinacin A (1, 5 and 10 mg/kg, i.p.; single dose) inhibits neuronal cell death in SAM rats with transient stroke and suppresses the expression of inflammatory cytokines in SAM brain tissues with transient stroke[4]. (+)-Erinacin A (1, 2 and 5 mg/kg, i.p.; once a day for 5 days) significantly reduces tumor volume in DLD-1 xenograft mice[5].
| Animal Model: | DLD-1 xenograft mouse model[5]. |
| Dosage: | 1, 2 and 5 mg/kg |
| Administration: | Intraperitoneal injection (i.p.) once a day for 5 days |
| Result: | Inhibited tumor volume by 60%, 32% and 26%. |
| Animal Model: | SAM rats with transient stroke[4]. |
| Dosage: | 1, 5 and 10 mg/kg |
| Administration: | Intraperitoneal injection (i.p.) single dose |
| Result: | Induced NeuN immune response in the entire brain region of SAM rats, and increased the number of NeuN cells. Inhibited the activation of iNOS and p38/MAPK pathways and the expression of CHOP and nitrotyrosine proteins in rat brain tissue. |
References
[1] HIROKAZU KAWAGISHI ∗ . Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum[J]. Tetrahedron Letters, 1994, 35 10: Pages 1569-1572. DOI: 10.1016/s0040-4039(00)76760-8
[2] CHIEN-CHANG LU . Inhibitory effect of Erinacines A on the growth of DLD-1 colorectal cancer cells is induced by generation of reactive oxygen species and activation of p70S6K and p21[J]. Journal of Functional Foods, 2016, 21: Pages 474-484. DOI: 10.1016/j.jff.2015.12.031
[3] KAM-FAI LEE. Post-Treatment with Erinacine A, a Derived Diterpenoid of H. erinaceus, Attenuates Neurotoxicity in MPTP Model of Parkinson’s Disease.[J]. Antioxidants, 2020. DOI: 10.3390/antiox9020137
[4] PEI-CHIEN HSU . Erinacine A attenuates glutamate transporter 1 downregulation and protects against ischemic brain injury[J]. Life sciences, 2022, 306: Article 120833. DOI: 10.1016/j.lfs.2022.120833
Erinacine A Erinacin ASupplier
- Tel
- 0755-0755-66853366 13670046396
- sales@chem-strong.com
- Tel
- 021-64340559 13651849907;
- xinyu_shi@jwypharmlab.com.cn
- Tel
- 526763801 13301653310
- 526763801@qq.com
- Tel
- 0571-89903882 18679456698
- mingxinzhu@huidabiotech.com
- Tel
- 021-58432009 400-005-6266
- marketing1@energy-chemical.com